2020 Tennessee CFAR Developmental Core Awards Funding Opportunity Announcement (FOA)
The Tennessee Center for AIDS Research (TN-CFAR) is requesting applications for 2020 CFAR Developmental Core Awards. These awards are intended to support studies for short periods of time (~1 year) to develop preliminary data for highly competitive extramural research applications.
The highest priority of this program is to support:
- New investigators who do not have existing independent (e.g., R01) HIV research funding from the NIH. Fellows and recipients of mentored training grants (e.g. K awards) are welcome to apply. For the NIH definition of New Investigator see http://grants.nih.gov/grants/new_investigators/#definition.
This program may also support:
- Established investigators who are new to HIV research and have not previously received independent research awards such as an R01 in HIV/AIDS.
- Feasibility studies.
- Emerging research opportunities.
- HIV research activities of newly recruited faculty.
Letter of Intent (LOI) is encouraged in advance for all submission. Send to firstname.lastname@example.org
Application Deadline is March 1, 2020 (Applications should be submitted directly to email@example.com with request for confirmation of receipt)
After receipt of an LOI, participants will be placed in contact with the CFAR Data Science Core (DSC) to discuss study design, analysis plans, and feasibility.
Applications are encouraged from any research discipline (clinical, translational, community, basic science, epidemiology, etc.). The CFAR will assure that early-stage investigators develop and maintain mentoring with established investigators so that they may acquire skills necessary for a career in HIV research.
See Section IV for application components and templates.
Applications that are most responsive to this FOA will meet at least one of the following criteria, as appropriate for the science being proposed:
- Have a high likelihood of leading to a strong extramural peer-reviewed grant application; This criterion is required for CFAR Research Project Awards, and is encouraged for CFAR Mission Awards (award types are defined below).
- Involve cross-institutional collaboration between investigators and/or trainees at Vanderbilt, Meharry Medical College, the Tennessee Department of Health, and/or Nashville CARES.
HIGH PRIORITY TOPICS FOR NIH RESEARCH FUNDING:
Applications should address a High Priority Topic for NIH support using AIDS-designated funds (Details available at NOT-OD-20-018 and on this webpage.)
Applications are also encouraged to include at least one of the following:
- Meaningfully engage community partners (i.e. Community Engaged Research).
- Utilize services of CFAR Cores (Clinical, Laboratory, and/or Data Science Cores).
Awards cannot support clinical research studies that include randomization to one or more low risk interventions to evaluate effects on biomedical or behavioral outcomes (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-106.html ).
After submission of LOI, all applicants will be contacted by the CFAR Data Science Core (DSC) to discuss study design, analysis plans, and feasibility.
Additionally, before submitting an application, all applicants are encouraged to discuss their project with a Community Engaged Research investigator and/or relevant community stakeholder group to identify opportunities for community engagement.
WHO MAY APPLY:
An applicant may be junior faculty member (Instructor or Assistant Professor), a post-doctoral fellow about to join the faculty (with letter from the Department Chair or Division Chief stating planned faculty appointment), or an established investigator (i.e., Associate or Full Professor) at Vanderbilt or Meharry Medical College who is new to HIV research. We encourage applications from women, minority, and LGBTQI individuals. Recipients of mentored training grants (e.g. K awards or VA CDA awards) are encouraged to apply. Employees of the Tennessee Department of Health or Nashville CARES may also apply, preferably in partnership with one or more Vanderbilt or Meharry faculty members.
All potential applicants should contact the Tennessee CFAR early in the proposal planning process for guidance on making the application most responsive to this FOA. This will include how to best leverage available CFAR Core services, and how to connect with the DSC, Community Engaged Research investigator, and/or community stakeholders. For further information and questions, please contact: firstname.lastname@example.org or Heather Burgess (email@example.com) at 615-343-7408
I. CATEGORIES OF SUPPORT
- CFAR Research Project Awards
Up to $50,000 per award, each for a duration of 12 months. Funding will begin as early as April 1, 2020, and will end on March 31, 2021. No cost extensions (NCE) will be considered contingent on available funds to CFAR. Likelihood of leading to a new funded NIH research grant application will be weighed heavily when evaluating CFAR Research Project applications.
The proposal must be for a new project or idea that is distinct from any currently funded project. Salary support can only be requested for faculty who are not tenured, and as is allowed based on other support the applicant may be receiving. Equipment requests are not allowed under this category.
- CFAR Mission Awards
Up to $20,000 per award, each for a duration of 12 months. Funding will begin as early as April 1, 2020. No cost extensions (NCE) will be considered contingent on available funds to CFAR. Likelihood of leading to a new funded NIH research grant application is encouraged but will not be weighed as heavily when evaluating CFAR Mission applications.
This award is intended to support applications that align with specific aims of the Tennessee CFAR. These include creating new opportunities for HIV clinical/translational research at Meharry, and between Meharry and Vanderbilt, supporting junior investigator career development, and work toward developing a new emphasis on HIV-focused community engaged research (CEnR). This also includes collaborative work between Meharry, Vanderbilt, the Tennessee Department of Health and/or Nashville CARES that does not fall under the scope of a Research Project Award.
II. LETTER OF INTENT (due February 1, 2020)
The letter should include a provisional title, a brief description of your anticipated project, how you fit eligibility criteria (see below), the program for which you are applying (Research Project or Mission award), and your contact information (include email address). Also include names of project co-investigator(s), collaborator(s), and/or mentor(s), as appropriate. The purpose of this brief letter is to allow CFAR to contact you with advice about preparing a competitive application, and to link you with the Data Science Core to discuss the study design and analysis plan of your proposal. Therefore, expect to be contacted soon after submission of your Letter of Intent. Full applications will be due March 1, 2020. In the Letter of Intent, explicitly indicate which NIH Priority Topic(s) the project will address (List of priorities for NIH support using AIDS-designated funds available at NOT-OD-20-018 and on this webpage.)
III. GENERAL POLICIES
The following guidelines apply to each of the two funding categories:
Principal investigator must be a Faculty member of Meharry Medical College or Vanderbilt University. This includes any faculty level investigator including Research Associates and Instructors, as well as more senior faculty. A post-doctoral fellow about to become junior faculty may apply with an accompanying letter stating that from their Department chair or Division chief. Employees of the Tennessee Department of Health or Nashville CARES may also apply, preferably in partnership with one or more Vanderbilt or Meharry faculty members.
Applicants can re-apply for CFAR support for a different project as long as support would not be for more than two continuous years.
B. Funding Dates
The start date for all funded applications will be April 1, 2020 (at earliest, pending compliance with necessary approvals). Funding end March 31, 2021.
C. Review Process
Applications will be reviewed internally by a panel of faculty chosen by CFAR leadership. Expertise relevant to all applications will be solicited, and review is modeled on a standard NIH study section. Written critiques will be provided to the applicant upon completion of review and ranking of the application. This will be useful for subsequent applications for external funding.
Studies that include research activities above minimal risk or involve vulnerable populations, or contain an international component, require an additional review by the CFAR at NIAID. Developmental Core Awards cannot support clinical trials.
All funding decisions are final. However, unfunded applicants are encouraged to engage with the Developmental Core to improve their applications for the subsequent cycle.
D. Change of Institution/Transfers
Recipients may not transfer these awards to another institution or to another individual. Reallocations in the approved budget (beyond 10% of the total budget) require prior written approval from the Developmental Core before expenditure. Awardees are required to give 90 days notice of any change in Institution. Funds will be pro-rated when an applicant leaves the Institution within any funding year.
A copy of any manuscripts or abstracts accepted for publication/presentation, which contains any results found using funds from a CFAR Developmental Core Award should be sent to the Tennessee Center for AIDS Research upon notification of acceptance.
Support from the Vanderbilt-Meharry Center for AIDS Research MUST be acknowledged when findings are reported, published or publicity is given to the work. Acknowledgement such as “This work was funded in part [or entirely] by a 201[X] Developmental Core award from the NIH-funded Tennessee Center for AIDS Research (P30 AI110527)” is required.
No-cost extensions beyond the approved funding period must be requested in writing, must be approved by the CFAR Developmental Core Director, and may not exceed 12 months.
The Tennessee Center for AIDS Research should be notified of any intentions to submit grants containing any results found using funds from the Development Award, so that CFAR personnel can document this contribution, and assist and provide support as needed.
Awards are made with the understanding that the Tennessee Center for AIDS Research will receive written notification of the filing of a patent application for any discovery made based on work funded by these grants.
If a grant recipient fails to comply with the terms and conditions of an award, funding will be terminated. In the event of cancelation/termination, unexpended funds must be returned to Tennessee CFAR Developmental Core.
If support for the proposed project is obtained from other sources, the recipient must notify the CFAR Developmental Core Director. Any funds awarded by this program will be withdrawn when funding is received for the same project from other sources, thus permitting Tennessee CFAR to invest in other research projects and investigators.
J. Human Subjects
All human subjects must give their prior, legally acceptable consent (if a minor, legally acceptable consent of a parent or legal guardian) to take part in any research project funded in whole or in part by this program. Institutional policy for human subjects must be followed and the procedures involved will be as stringent as those imposed by the NIH. Budgets will not be approved prior to receipt of the IRB approval letter, if needed.
K. Laboratory Animals
The Principal Investigator must follow standards for care of laboratory animals as prescribed in the DHHS Publication 85-23 (NIH). Budgets will not be approved prior to receipt of the IACUC approval letter, if needed.
L. Data Sharing
In accord with NIH policy, all primary research data generated with Tennessee CFAR support will be available for sharing no later than the acceptance for publication of the main findings from the final data set. Even if primary research data are stripped of all personal identifiers, it is possible for deductive disclosure of subjects with unusual characteristics. Therefore, in order to maintain privacy (per HIPAA), data and associated documentation will be available only under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and to NOT identifying any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning all data after analyses are complete. The data sharing agreement will also require acknowledgement of the Tennessee CFAR as the source of data and will request pre-release review of any presentations or publications by the Tennessee CFAR PI (or the PI who generated the primary data). Agreement to provide financial support for itemized specific expenses of data sharing may also be required in the data sharing agreement.
IV. ADMINISTRATION OF TENNESSEE CENTER FOR AIDS RESEARCH DEVELOPMENTAL AWARDS
A. Application Sections:
The maximum Research Plan length is 5 pages (excluding references); the sections of the Research Plan are described below. Applications that exceed the page limitation will be returned to the applicant. The face page (Form Page 1) and budget template (Form Page 4) are from the standard PHS 398 Grant Application packet, which may be found on the web at: http://grants.nih.gov/grants/funding/phs398/phs398.html. Please note that page 1 (front page) does not need to be signed by a University official, only the Principal Investigator. On line 2 of the PHS 398 face page, please indicate the application category (i.e., Interdisciplinary HIV/AIDS Research Project or New HIV/AIDS Pilot Projects). Applicants are encouraged to engage their institutional grants office to prepare the PHS 398 face page and budget form. Appended materials will not be accepted or considered as part of the application. A Conflict of Interest Statement is not required.
A complete application packet should include the following:
- PHS 398 face page
- Research Plan (5 pages, excluding references)
- A brief paragraph describing how application is relevant to HIV/AIDS and the priorities for NIH support using AIDS-designated funds (available at NOT-OD-20-018 and on this webpage). This paragraph should be a separate page, but may duplicate text in the Research Plan.
- NIH biosketches from PI(s) and all co-investigators
- PHS 398 budget (limited to one year of funding)
- Letters of support from collaborators essential to the success of the proposed project
- Senior post-doctoral fellow or junior faculty applicants must provide a letter of departmental support outlining the commitment of the department to the applicant’s career
- If applicable, include the CFAR International Checklist or Clinical Checklist if the study involves above minimal risk, vulnerable populations, or international research. https://www.niaid.nih.gov/research/cfar-research-project-guidelines (please contact the Developmental Core with questions on these forms or whether proposed project could be funded by CFAR).
Content of Research Plan (limit to 5 pages for sections 1-5):
1. Specific Aims and Hypothesis
- Long-term objectives and goals
- Specific aims
- Explicit statement indicating which NIH Priority Topic(s) the project will address (List of priorities for NIH support using AIDS-designated funds available at NOT-OD-20-018 and on this webpage.)
2. Background and Significance
- Describe the effect of these studies on the concepts, methods, technologies, treatments, services or preventative interventions that drive this field.
- This section should be very concise.
3. Preliminary Studies/Progress Report
- Preliminary data are not required for an application from a new investigator for a Pilot HIV/AIDS research project. However, inclusion of preliminary data, when possible, will be considered a plus in scoring of a new investigator’s application. A new investigator is defined as per the NIH definition (above and http://grants.nih.gov/grants/new_investigators/#definition).
- Preliminary data are required from an applicant who is not an NIH-defined new investigator.
4. Research Design and Methods
Describe the following:
- Research design conceptual or clinical framework, procedures, and analyses
- Data collection, analysis, interpretation, and sharing plan
- New methodology and its advantage over existing methodologies
- Novel concepts, approaches, tools, or technologies
- Potential difficulties and limitations
- Any hazardous procedures, situations, or materials and the precautions to be exercised
- Tentative sequence or timetable (i.e. schedule of events) for the project as well as inclusion/exclusion criteria.
5. Sample Size Justification and Statistical Analysis Plan – THIS SECTION MUST BE COMPLETED
Describe in detail your sample size justification and how the data will be collected, analyzed, and interpreted.
May include, but is not limited to, the following: sample size, power analysis, statistical tests, description of statistical analysis including P-values and confidence intervals, and name of primary biostatistician who worked with the PI on the research plan (if any).
6. References (not included in 5 page limit)
7. Human subjects - as needed
8. Vertebrate animals - as needed
All applications must include an itemized budget, utilizing the Initial Budget Period (Form Page 4) of the PHS 398 application forms available at: http://grants.nih.gov/grants/funding/phs398/phs398.html. The Developmental Core can assist with budget questions as needed. Funds provided by this program may be expended only for purpose and in the amounts set forth in the budget, unless written consent from the CFAR Developmental Core Director is obtained prior to the expenditure. The grantee may reallocate funds from one expense category to another without the prior approval of the CFAR Developmental Core Director provided that the reallocation does not exceed 10% of the amount of the total direct costs.
If the amount of a grant award is less than the amount requested in the grant application, the grantee shall submit to the CFAR Developmental Core Director a revised itemized budget not exceeding the amount of the grant award. All funding requests must be made in U.S. dollars.
1. Allowable Costs:
- Salaries of postdoctoral associates, graduate student assistants, and research assistants
- Patient costs
- Travel – A maximum of up to $1,000 (U.S.) is permitted to attend a professional meeting in which research funded by this application is presented.
- Investigator salaries should be requested to reflect their % effort on the proposed project and the budget must be adequate to perform the project (e.g., include supply costs or indicate what other sources of support will be used),
- CFAR or other Core facility charges
2. Tennessee CFAR Developmental Awards may not be used for any of the following:
- Renovation of physical facilities
- Telephone services
- Laboratory or office furniture
- Dues and membership in scientific societies or journal subscriptions
- Recruiting fees and relocation expenses
- Maintenance contracts
- Computer equipment that is not essential for the research project at hand
- Studies involving new drugs, treatments, or devices, or off-label use of a licensed drug
- Clinical trials
C. Review Criteria:
Impact and originality of idea, ability of PI to carry out award, the prospect of successfully applying for further funding, and scientific merit of research design, approach, and methodology. Proposals from junior investigators and faculty new to HIV research will be given special consideration in the review process. Proposals not judged as relevant to HIV/AIDS will not be reviewed.
D. Reporting and Presenting Requirements:
After each 3 months of funding, awardees will be required to submit a brief written progress report to Tennessee CFAR. After 12 months of funding, awardees will be required to present study results at a Tennessee CFAR seminar.
E. Final Progress Report
A final written report is due 90 days after termination of the grant. This report should detail major accomplishments and publications obtained as a result of the funding, and a list of new grants submitted as a result of this funding.